BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Morozov VA, Lagaye S. Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol 2018; 10(2): 186-212 [PMID: 29527256 DOI: 10.4254/wjh.v10.i2.186]
URL: https://www.wjgnet.com/1007-9327/full/v10/i2/186.htm
Number Citing Articles
1
Setareh Mobasheri, Nazanin Irani, Abbas Akhavan Sepahi, Fatemeh Sakhaee, Fatemeh Rahimi Jamnani, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh. Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection. Gene 2018; 676 doi: 10.1016/j.gene.2018.07.023
2
Abdulrazzaq N. Zghair, Nazar Sh. Mohammed, Sumayah Faruq Kasim. Gene Sequencing of Hepatitis C Virus Isolated from Patients with Liver Diseases. Journal of Pure and Applied Microbiology 2023; 17(2) doi: 10.22207/JPAM.17.2.08
3
Runzhou Yu, Syed Muhammad Umer Abdullah, Yanni Sun. HMMPolish: a coding region polishing tool for TGS-sequenced RNA viruses. Briefings in Bioinformatics 2023; 24(5) doi: 10.1093/bib/bbad264
4
Berin Karaman Mayack, Muhammed Moyasar Alayoubi, Hakan Mikail Gezginci. In silico design of potential HCV NS5B inhibitors: a comprehensive approach combining combinatorial library generation, ensemble docking, MM-GBSA calculations, QSAR model development, and molecular dynamics. Journal of Research in Pharmacy 2025; 29(2) doi: 10.12991/jrespharm.1634330
5
Yini Pan, Zhenxin Wang, Zhichao Yan, Haofan Sun, Lingyi Zhang, Weibing Zhang. Novel Strategy for Screening Target Proteins by the Common Drugs─Sofosbuvir-Specific Profiling of HCV Patient Serum. Analytical Chemistry 2024; 96(23) doi: 10.1021/acs.analchem.4c00993
6
Gusti Rizaldi, Achmad F. Hafid, Tutik S. Wahyuni. Promising alkaloids and flavonoids compounds as anti-hepatitis c virus agents: a review. Journal of Public Health in Africa 2023; 14(1) doi: 10.4081/jphia.2023.2514
7
Amany Belal, Aly Abdou, Samar F. Miski, Mohamed A. M. Ali, Heba I. Ghamry, Ahmad J. Obaidullah, Mohamed Y. Zaky, Ahmed H. E. Hassan, Eun Joo Roh, Ahmed A. Al-Karmalawy, Mona H. Ibrahim. Exploring the potential of some natural indoles as antiviral agents: quantum chemical analysis, inverse molecular docking, and affinity calculations. Frontiers in Chemistry 2025; 12 doi: 10.3389/fchem.2024.1521298
8
Novie Amelia Chozie, Melati Arum Satiti, Damayanti Rusli Sjarif, Hanifah Oswari, Ni Ken Ritchie. The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: a single-center experience. Blood Research 2022; 57(2) doi: 10.5045/br.2022.2021219
9
Marta M Gaglia, Karl Munger. More than just oncogenes: mechanisms of tumorigenesis by human viruses. Current Opinion in Virology 2018; 32 doi: 10.1016/j.coviro.2018.09.003
10
Mohammad Darvishi, Reza Amiri, Emad Ghannad, Samir Mehrabkhani, Nassim Rastgar, Mahkameh Razaghi, Jaya Bansal, Mamata Chahar, Pranchal Rajput, Hossein Saffarfar, Payam Ali-Khiavi, Ahmad Mobed, Yalda Yazdani. Nanodiagnostics in global eradication of hepatitis C virus. Clinica Chimica Acta 2025; 565 doi: 10.1016/j.cca.2024.120013
11
12
Anjar Hermadi Saputro, Aluicia Anita Artarini, Daryono Hadi Tjahjono, Sophi Damayanti. The long and stumble way to find potential active compounds from plants for defeating hepatitis B and C: review. Pharmacia 2022; 69(3) doi: 10.3897/pharmacia.69.e85160
13
14
Paulo Fernando da Silva Santos-Júnior, João Xavier de Araújo-Júnior, Edeildo Ferreira da Silva-Júnior. Inhibitors Targeting Hepatitis C Virus (HCV) Entry. Mini-Reviews in Medicinal Chemistry 2023; 23(11) doi: 10.2174/1389557522666220428115152
15
Ranjan Kumar Barman, Anirban Mukhopadhyay, Ujjwal Maulik, Santasabuj Das. Identification of Critical Host Targets for HCV Infection: A Systems Biology Approach. Transactions of the Indian National Academy of Engineering 2021; 6(3) doi: 10.1007/s41403-021-00239-6
16
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11) doi: 10.3390/cancers14112700
17
Tomás G. Villa, Ángeles Sánchez-Pérez, Carmen Sieiro. Oral lichen planus: a microbiologist point of view. International Microbiology 2021; 24(3) doi: 10.1007/s10123-021-00168-y
18
Skender Topi, Elona Gaxhja, Ioannis Alexandros Charitos, Marica Colella, Luigi Santacroce. Hepatitis C Virus: History and Current Knowledge. Gastroenterology Insights 2024; 15(3) doi: 10.3390/gastroent15030049
19
Agnieszka Styczeń, Martyna Krysa, Paulina Mertowska, Ewelina Grywalska, Tomasz Urbanowicz, Maciej Krasiński, Malwina Grobelna, Weronika Topyła-Putowska, Mansur Rahnama-Hezavah, Michał Tomaszewski. The Role of Toll-like Receptors and Viral Infections in the Pathogenesis and Progression of Pulmonary Arterial Hypertension—A Narrative Review. International Journal of Molecular Sciences 2025; 26(22) doi: 10.3390/ijms262211143
20
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
21
Yoshihito Nagura, Takanori Suzuki, Kentaro Matsuura, Shintaro Ogawa, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka. Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents. Hepatology Research 2024; 54(1) doi: 10.1111/hepr.13962
22
Nour Mammari, Ysaline Krier, Quentin Albert, Marc Devocelle, Mihayl Varbanov. Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections. Pharmaceuticals 2021; 14(8) doi: 10.3390/ph14080774
23
Korra Bhanu Teja, Sridivya Bhagavatula, Aishwarya Bhatta, Shilpa J. Tomar. Emerging Human Viral Diseases, Volume II. 2024;  doi: 10.1007/978-981-97-4480-0_20
24
Hui Tian, Zhenkun He. miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling. Yonsei Medical Journal 2018; 59(4) doi: 10.3349/ymj.2018.59.4.511
25
Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, Mariana Michelle Ramírez-Mejía. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals. Pathogens 2024; 13(4) doi: 10.3390/pathogens13040339
26
Mohamed Nabil, Mohammed H. Saiem Al-Dahr, Ahmed Haridi, Waleed S. Mohamed, Ezeldine K. Abdalhabib, Bi Bi Zainab Mazahari. Monitoring the Treatment of Hepatitis C Viral Infection by Molecular Techniques. Journal of Biosciences and Medicines 2019; 7(11) doi: 10.4236/jbm.2019.711008
27
Fatima Butt, Muhammad Shahid, Muhammad Hassan, Farah Tawakkal, Iram Amin, Samia Afzal, Rashid Bhatti, Rabia Nawaz, Muhammad Idrees. A review on hepatitis C virus: role of viral and host-cellular factors in replication and existing therapeutic strategies. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00232-w
28
Gabriel L. Costa, Giuseppe A. Sautto. Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response. Expert Review of Vaccines 2025; 24(1) doi: 10.1080/14760584.2025.2452955
29
Ahmed S. Abdel‐Moneim. Occult hepatitis C infections: time to change the defined groups. Microbiology and Immunology 2019; 63(11) doi: 10.1111/1348-0421.12737
30
Ali Ahmed Al-Hadheq, Bashir Ahmed Al-Ofairi, Adam Dawoud Abakar, Azhari Mohammed, Wadhah Hassan Edrees, Wadee Abdullah Al-Shehari, Ahmed Salem Al-Jendy, Yosria Mohammed Elsiddig, Abdulrahman Abdullah Humaid. Serological and molecular detection of hepatitis C virus in Amran governorate, Yemen. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-11832-3
31
Raissa Martins Deodato, Mayara Torquato Lima da Silva, Eduarda Oliveira Queiroz, João Pedro Henriques dos Santos Mendonça, Kathleen Victoria Vieira da Silva, Isabella de Mattos Velasco Guido, Livia Melo Villar. Recombinant multiepitope proteins for hepatitis C virus diagnosis: Systematic review. International Journal of Biological Macromolecules 2026; 361 doi: 10.1016/j.ijbiomac.2026.151920
32
Varimadugu Aruna, A. Sneha, D. Sai Harshitha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022;  doi: 10.1016/B978-0-323-98806-3.00022-2
33
Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri. Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals. F1000Research 2022; 11 doi: 10.12688/f1000research.109397.1
34
B. Dominguez-Molina, K. Machmach, C. Perales, L. Tarancon-Diez, I. Gallego, J. L. Sheldon, M. Leal, E. Domingo, E. Ruiz-Mateos, Bryan R. G. Williams. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells. Journal of Virology 2018; 92(23) doi: 10.1128/JVI.01219-18
35
Érica da Silva Anselmo, Ana Paula Schermack, Líncon Bordignon Somensi, Alan Christhian Bahr, Elizama De Gregório. A IMPOSSIBILIDADE DO TRATAMENTO FARMACOLÓGICO PARA HEPATITE C CRÔNICA DEVIDO À INTERAÇÕES MEDICAMENTOSAS. Revista Contemporânea 2023; 3(6) doi: 10.56083/RCV3N6-052
36
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2021;  doi: 10.1016/B978-0-7020-7584-1.00006-1
37
Tom Domovitz, Meital Gal-Tanamy. Tracking Down the Epigenetic Footprint of HCV-Induced Hepatocarcinogenesis. Journal of Clinical Medicine 2021; 10(3) doi: 10.3390/jcm10030551
38
Vidya Ramdas, Rashmi Talwar, Moloy Banerjee, Advait Arun Joshi, Amit Kumar Das, Deepak Sahebrao Walke, Prashant Borhade, Usha Dhayagude, Rajesh Loriya, Ganesh Gote, Apparao Bommakanti, Aruna Sivaram, Gautam Agarwal, Arnab Goswami, Prashant Nigade, Maneesh Mehta, Vinod Patil, Dipak Modi, Hemant Kumar, Sadanand Mallurwar, Amruta Dash, Falguni Modi, Sandip Kuldharan, Pratima Srivastava, Minakshi Singh, Lakshmi Narasimham, Jayasagar Gundu, Sharad Sharma, Rajender Kumar Kamboj, Venkata P. Palle. Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate. Journal of Medicinal Chemistry 2019; 62(23) doi: 10.1021/acs.jmedchem.9b01562
39
Maryam Pourdehghan Jigheh, Zahra Zenderuh Ravanlo, Mahya Zarei Shahrak, Aria Mohabbat, Hossein Bannazadeh Baghi. Targeting human oncogenic viruses with CRISPR/Cas: New therapeutic opportunities and challenges. Biomedicine & Pharmacotherapy 2026; 198 doi: 10.1016/j.biopha.2026.119284
40
И.О. Стома, З.А. Цейко, Е.В. Воропаев, А.А. Ковалев, О.В. Осипкина, А.П. Демчило, А.А. Зятьков, А.С. Шафорост. Генотип вируса гепатита С как фактор, определяющий состав кишечной микробиоты: сравнительный метагеномный анализ . Клиническая инфектология и паразитология 2026; 15(1) doi: 10.34883/PI.2026.15.1.038
41
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, Thomas F. Baumert, Joachim Lupberger. Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip. International Journal of Molecular Sciences 2020; 21(9) doi: 10.3390/ijms21093057
42
Mohammad Hadi Nematollahi, Mehrnaz Mehrabani, Yaser Hozhabri, Maryamossadat Mirtajaddini, Siavash Iravani. Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesis. Heliyon 2023; 9(10) doi: 10.1016/j.heliyon.2023.e20428
43
44
Duong Hoang Huy Le, Sitthichai Kanokudom, Ha Minh Nguyen, Ritthideach Yorsaeng, Sittisak Honsawek, Sompong Vongpunsawad, Yong Poovorawan. Hepatitis C Virus—Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical Outcomes. Viruses 2024; 16(12) doi: 10.3390/v16121863
45
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidics. Analytical Methods 2021; 13(6) doi: 10.1039/D0AY02045A
46
Anne Olbrich, Hedda Wardemann, Stephan Böhm, Karen Rother, Che C Colpitts, Florian Wrensch, Thomas F Baumert, Thomas Berg, Julia Benckert. Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis C. The Journal of Infectious Diseases 2019; 220(7) doi: 10.1093/infdis/jiz274
47
Reem El-Shenawy, Sally Farouk, Naiera Helmy, Noha Bader El Din. Hepatitis C - Recent Advances. 2023;  doi: 10.5772/intechopen.1001057
48
娜娜 李. Related Research Progress in Genotyping of Hepatitis C Virus. Advances in Clinical Medicine 2023; 13(05) doi: 10.12677/ACM.2023.1351061
49
Junjie Liu, Tong Yuan, Lin Xue, Huifang Liang. Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D. Virology Journal 2025; 22(1) doi: 10.1186/s12985-025-02907-3
50
Muhammad Kashif, Muhammad Irfan Majeed, Muhammad Asif Hanif, Ateeq ur Rehman. Surface Enhanced Raman Spectroscopy of the serum samples for the diagnosis of Hepatitis C and prediction of the viral loads. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2020; 242 doi: 10.1016/j.saa.2020.118729
51
Bianca Manole, Costin Damian, Simona-Eliza Giusca, Irina Draga Caruntu, Elena Porumb-Andrese, Catalina Lunca, Olivia Simona Dorneanu, Luminita Smaranda Iancu, Ramona Gabriela Ursu. The Influence of Oncogenic Viruses in Renal Carcinogenesis: Pros and Cons. Pathogens 2022; 11(7) doi: 10.3390/pathogens11070757
52
53
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021;  doi: 10.2478/sjecr-2021-0010
54
Le Chang, Wei Duan, Chuang Wang, Jian Zhang. miRNA-126 Inhibits Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells (BMSCs). Journal of Biomaterials and Tissue Engineering 2022; 12(4) doi: 10.1166/jbt.2022.2943
55
Amanpreet Singh, Ashima Kukkar. Data Science and Artificial Intelligence for Digital Healthcare. Signals and Communication Technology 2024;  doi: 10.1007/978-3-031-56818-3_5
56
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV Infection. Journal of Clinical Medicine 2021; 10(15) doi: 10.3390/jcm10153218
57
Rajdeep Shaw, Bhramar Dutta, Dipanjana Ghosh, Rajib Bandopadhyay. Hepatitis C—Route of Asymptomatic to Symptomatic Switch in Raising Hepatocarcinogenesis: Revisiting Nobel Prize 2020 in Physiology and Medicine. National Academy Science Letters 2023; 46(1) doi: 10.1007/s40009-022-01192-w
58
Vukica Đorđević, Dobrila Stanković Đorđević, Branislava Kocić, Marina Dinić, Danka Sokolović, Jana Pešić Stanković, Daniele Vergara. The Impact of Hepatitis C Virus Genotypes on Oxidative Stress Markers and Catalase Activity. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/6676057
59
Mahmood Reza Masoudi, Alireza Rafati. Immunogenicity against hepatitis C virus with mesenchymal stem cells of inbreed BALB/c mice sub cloned with HCVcp protein gene. Transplant Immunology 2022; 74 doi: 10.1016/j.trim.2022.101651
60
Teshiwal Deress, Yihenew Million, Teshome Belachew, Mohabaw Jemal, Mekonnen Girma, Gianandrea Pasquinelli. Seroprevalence of Hepatitis C Viral Infection in Ethiopia: A Systematic Review and Meta-Analysis. The Scientific World Journal 2021; 2021 doi: 10.1155/2021/8873389
61
Vikram B Vikhe, Vivek H Lapsiwala, Ahsan A Faruqi, Tejas Kore, Ahanaa Chakraborty. An Interesting Case of Acute Transverse Myelitis Secondary to Hepatitis C and Tricuspid Valve Endocarditis: A Case Report. Cureus 2024;  doi: 10.7759/cureus.75312
62
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virus. Genes & Immunity 2019; 20(5) doi: 10.1038/s41435-019-0066-z
63
Umesh Kumar Lilhore, Poongodi Manoharan, Jasminder Kaur Sandhu, Sarita Simaiya, Surjeet Dalal, Abdullah M. Baqasah, Majed Alsafyani, Roobaea Alroobaea, Ismail Keshta, Kaamran Raahemifar. Hybrid model for precise hepatitis-C classification using improved random forest and SVM method. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-36605-3
64
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review). Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6987
65
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine & Growth Factor Reviews 2019; 50 doi: 10.1016/j.cytogfr.2019.10.006
66
Piu Samui, Jayanta Mondal. Mathematical Analysis and Applications in Biological Phenomena through Modelling. Springer Proceedings in Mathematics & Statistics 2025; 478 doi: 10.1007/978-981-97-9194-1_13
67
Noha H. Habashy, Marwa M. Abu-Serie. Major royal-jelly protein 2 and its isoform X1 are two novel safe inhibitors for hepatitis C and B viral entry and replication. International Journal of Biological Macromolecules 2019; 141 doi: 10.1016/j.ijbiomac.2019.09.080
68
Antoni Sicras Mainar, Ruth Navarro Artieda, Ignacio Hernández, Ramón Morillo. Prevalence of the potential drug–drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain. Gastroenterología y Hepatología (English Edition) 2019; 42(8) doi: 10.1016/j.gastre.2019.09.001
69
Noha G. Bader El Din, Sally Farouk. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection. Journal of Interferon & Cytokine Research 2024; 44(6) doi: 10.1089/jir.2024.0003
70
Özkan FİDAN. Investigation of Antiviral Potential of Food Carotenoids and Apocarotenoids against RNA-dependent RNA Polymerase of Hepatitis C Virus. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi 2022; 11(3) doi: 10.17798/bitlisfen.1161170
71
Anastasia Pechelyulko, Zhanna Andreeva-Kovalevskaya, Dmitriy Dmitriev, Viacheslav Lavrov, Yulia Massino, Alexey Nagel, Olga Segal, Olga S. Sokolova, Alexander Solonin, Yulia Tarakanova, Alexander Dmitriev. A simple method to purify recombinant HCV core protein expressed in Pichia pastoris for obtaining virus-like particles and producing monoclonal antibodies. Protein Expression and Purification 2021; 183 doi: 10.1016/j.pep.2021.105864
72
Nkosenhle L. Ndlovu, Andrew Scheibe, Harry Hausler, Mark W. Sonderup, C. Wendy Spearman, Katherine Young, Dawie Nel, Jason T. Blackard, Nishi Prabdial-Sing, Syed Hani Abidi. Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016–2017. PLOS One 2025; 20(12) doi: 10.1371/journal.pone.0336614
73
A.A. Khryanin, A.V. Sokolovskaia, V.K. Bocharova. Lichen planus associated with viral hepatitis C: new data, concepts and hypotheses. Russian Journal of Clinical Dermatology and Venereology 2023; 22(4) doi: 10.17116/klinderma202322041426
74
Ajit Kumar, Srinivasa Penumutchu, Love Panchariya, Priyanka Kumari, Shubham Thakur, Purba Daripa, Vandana Singh, Arockiasamy Arulandu, Souvik Maiti, Mandar V. Deshmukh, Niyati Jain. Loop of fate: structural and mechanistic insights into hnRNPA1 binding to the hepatitis C virus RNA. RNA 2026; 32(2) doi: 10.1261/rna.080770.125
75
Ali Almajid, Hassan Albarbari, Ali Bazroon, Hashim Al-Awami, Rahaf Aljurayyad, Razan Albadran , Zainab Alkhamis, Haider Alomair, Yamama Aljishi. Epidemiological Perspectives: A Four-Year Insight Into Hepatitis C Surveillance in the Kingdom of Saudi Arabia. Cureus 2024;  doi: 10.7759/cureus.52646
76
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of Hepatitis C Cure With Antivirals: Why Test and Treat?. Future Microbiology 2019; 14(5) doi: 10.2217/fmb-2019-0041
77
Luis F. Pereira, John J. Faragon, Antoine Douaihy, Courtney E. Kandler. HIV Psychiatry. 2022;  doi: 10.1007/978-3-030-80665-1_18
78
Anna S. Baber, Baviththira Suganthan, Ramaraja P. Ramasamy. Current advances in Hepatitis C diagnostics. Journal of Biological Engineering 2024; 18(1) doi: 10.1186/s13036-024-00443-2
79
SK Mohiuddin Choudhury, XuSheng Ma, Sahibzada Waheed Abdullah, HaiXue Zheng. Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses. Journal of Inflammation Research 2021;  doi: 10.2147/JIR.S295706
80
81
Adeline Kerviel, Mengyang Zhang, Nihal Altan-Bonnet. A New Infectious Unit: Extracellular Vesicles Carrying Virus Populations. Annual Review of Cell and Developmental Biology 2021; 37(1) doi: 10.1146/annurev-cellbio-040621-032416
82
Elena Zocca, Silva Seraceni, Teresa Cafaro, Tamara Emanuela Cervone, Laura Cardarelli, Massimiliano Valisi, Isabella Polidori, Massimo Pieri, Flaminia Tomassetti, Francesco Broccolo. Evaluation of Two-Assay Serological Testing Strategies for Anti-HCV Screening in Italian Populations: A Dual Screening Approach. Diagnostics 2024; 14(6) doi: 10.3390/diagnostics14060570
83
Sarmad Falah Hasan, Zeyad Khalaf Maded, Muhannad Abdulla Alazzawy. Molecular detection of Hepatitis C virus (HCV) genotypes and viral loads in chronic hcv infected patients in Kirkuk, Iraq. Medical Journal of Babylon 2023; 20(Supplement 1) doi: 10.4103/MJBL.MJBL_361_22
84
Sachin Kumar. Textbook of Gene Therapy. 2026;  doi: 10.1007/978-981-95-7688-3_9
85
Jennifer L Reed, Matthew A Butzler, Claudia A Hawkins, Yukari C Manabe, Jeffrey Holden, David L Thomas, Andrea L Cox, Sally M McFall. Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System. The Journal of Infectious Diseases 2026; 233(5) doi: 10.1093/infdis/jiaf608
86
Lucie Hozáková, Barbora Vokatá, Tomáš Ruml, Pavel Ulbrich. Targeting the Virus Capsid as a Tool to Fight RNA Viruses. Viruses 2022; 14(2) doi: 10.3390/v14020174
87
Kyo Izumida, Eiji Morita. The roles of HCV core protein and its binding host factor in virus assembly and release. Frontiers in Virology 2024; 4 doi: 10.3389/fviro.2024.1383261
88
V. M. Tsyrkunov, V. P. Andreev, R. I. Kravchuk. CLINICAL MORPHOLOGY OF THE LIVER: HEPATOCYTES, ENDOMEMBRANE SYSTEM. Hepatology and Gastroenterology 2019; 3(1) doi: 10.25298/2616-5546-2019-3-1-28-42
89
Yulia V. Ostankova, Diana E. Reingardt, Alexandr N. Schemelev, Thierno A. L. Balde, Sanaba Boumbaly, Areg A. Totolian. Experience with HCV Detection and Molecular Genetic Characterization among Otherwise Healthy Pregnant Women and Their Partners in the Republic of Guinea. Microorganisms 2024; 12(10) doi: 10.3390/microorganisms12101959
90
Enakshi Das, Mahesh Samantaray, Kajal Abrol, Jayarani Basumatari, Shilpa Sri Pushan, Amutha Ramaswamy. Development of a Multiple-Epitope-Based Vaccine for Hepatitis C Virus Genotypes 1a and 1b: an in-silico reverse vaccinology approach. In Silico Pharmacology 2024; 12(2) doi: 10.1007/s40203-024-00275-4
91
Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams framework. Health Research Policy and Systems 2019; 17(1) doi: 10.1186/s12961-019-0436-z
92
Alexis A. Hatton, Fermin E. Guerra. Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors. Viruses 2022; 15(1) doi: 10.3390/v15010052
93
Jia-Horng Kao, Chun-Yen Lin, Wan-Long Chuang, Yao-Yun Cheng, Jui-Yu Hu, Wen-Kai Liang, Peter Friebe, Stuart Palmer, Chin-Shiou Huang. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping. Diagnostic Microbiology and Infectious Disease 2019; 94(4) doi: 10.1016/j.diagmicrobio.2019.02.020
94
Bakht Biland, Mohsina Haq, Sardar Muhammad, Mohsan Subhani, Syed Gardezi, Najibul Haq, Nadeem Tehami. Frequency Distribution of Hepatitis C Virus Genotypes with Reference to Age and Sex in Various Districts of Khyber Pakhtunkhwa, Pakistan. EMJ Hepatology 2021;  doi: 10.33590/emjhepatol/20-00268
95
Maria Carla Liberto, Nadia Marascio. Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”. Journal of Clinical Medicine 2022; 11(2) doi: 10.3390/jcm11020359
96
Adam Al-Hakim, Mark Kacar, Sinisa Savic. The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review. Journal of Clinical Medicine 2024; 13(6) doi: 10.3390/jcm13061717
97
Po-Jen Hsiao, Chia-Jen Hsiao, Fu-Ru Tsai, Yen-Lin Hou, Chih-Chien Chiu, Wen-Fang Chiang, Kun-Lin Wu, Yuan-Kuei Li, Chen Lin, Jenq-Shyong Chan, Chi-Wen Chang, Chi-Ming Chu. From Bench to Bedside: Clinical and Biomedical Investigations on Hepatitis C Virus (HCV) Genotypes and Risk Factors for Albuminuria. Bioengineering 2022; 9(10) doi: 10.3390/bioengineering9100509
98
Hongbo Zhang, Hongdan Wang, Youcai An, Ze Chen. Construction and application of adenoviral vectors. Molecular Therapy Nucleic Acids 2023; 34 doi: 10.1016/j.omtn.2023.09.004
99
Shagufta Kamal, Asif Shahzad, Kanwal Rehman, Komal Tariq, Muhammad Sajid Hamid Akash, Muhammad Imran, Mohammed Ali Assiri. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus. Current Medicinal Chemistry 2024; 31(15) doi: 10.2174/0109298673234823230921090431
100
Shahina Mumtaz, Jawad Ahmed, Amina Gul, Shafiq Ahmed Tariq, Sami Siraj, Tahir Sarwar. Genetic Diversity of Hepatitis C Virus Genotype 3a Based on Complete Core Protein in Peshawar, Pakistan. Jundishapur Journal of Microbiology 2020; 13(3) doi: 10.5812/jjm.98942
101
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
102
Anna D. Kashnikova, Tatiana N. Bystrova, Anastasia V. Polyanina, Artem A. Zalesskikh. Genetic Monitoring as a Component of Hepatitis C Surveillance. ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2022;  doi: 10.35627/2219-5238/2022-30-11-76-81
103
Nur Amalin Zahirah Mohd Amin, Tuan Nur Akmalina Mat Jusoh, Ahmad Adebayo Irekeola, Rafidah Hanim Shueb. Hepatitis C: A Review on Current and Emerging Genotyping Assays. Malaysian Journal of Medicine and Health Sciences 2023; 19(5) doi: 10.47836/mjmhs.19.5.41
104
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virus. Microbes and Infection 2019; 21(5-6) doi: 10.1016/j.micinf.2019.06.008
105
Johan Noble, Thomas Jouve, Paolo Malvezzi, Lionel Rostaing. Renal complications of liver diseases. Expert Review of Gastroenterology & Hepatology 2018; 12(11) doi: 10.1080/17474124.2018.1530984
106
Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill, Shishir Shetty. Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma. Cancers 2022; 14(5) doi: 10.3390/cancers14051255
107
T.L. Hrydina . PECULIARITIES OF TREATMENT AND PREVENTION OF INFECTION CAUSED BY HEPATITIS C VIRUS. Review. Medical Science of Ukraine (MSU) 2022; 18(1) doi: 10.32345/2664-4738.1.2022.09
108
Paul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, Christian Heuss, Margaret Tulessin, Zhiqing Wang, Colin Förster, Alina C. Schneider, Jocelyn Quistrebert, Haiting Chai, Marvin Reineke, Louise Benning, Jonathan Honegger, Maike Hofmann, Robert Thimme, Jörg Timm, Graham S. Cooke, Sarah Pett, Leanne McCabe, Chris Jones, Richard Gilson, Sumita Verma, Stephen D. Ryder, Jane D. Collier, Stephen T. Barclay, Aftab Ala, Sanjay Bhagani, Mark Nelson, Chin Lye Ch’ng, Ben Stone, Martin Wiselka, Daniel Forton, Stuart McPherson, Rachel Halford, Dung Nguyen, David Smith, Emily Dennis, Fleur Hudson, Eleanor J. Barnes, Ann Sarah Walker, Paul Schnitzler, Uta Merle, Naglaa H. Shoukry, Julie Bruneau, Chaturaka Rodrigo, Andrew Lloyd, Rowena A. Bull, M. Azim Ansari, Carolin Mogler, John McLauchlan, Xavier Forns, Sofía Pérez-del-Pulgar, Volker Lohmann. Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-67174-w
109
K. Ghazal, O. Morales, C. Barjon, G. Dahlqvist, L. Aoudjehane, L. Ouaguia, N. Delhem, F. Conti. Early high levels of regulatory T cells and T helper 1 may predict the progression of recurrent hepatitis C after liver transplantation. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3) doi: 10.1016/j.clinre.2018.10.005
110
Satoshi Muraoka, Weiwei Lin, Mei Chen, Samuel W. Hersh, Andrew Emili, Weiming Xia, Tsuneya Ikezu. Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids. Methods 2020; 177 doi: 10.1016/j.ymeth.2020.02.002
111
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
112
Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Shintaro Ogawa, Kei Fujiwara, Shunsuke Nojiri, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka. Serum angiopoietin‐2 levels predict regression of Mac‐2 binding protein glycosylation isomer‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents. Hepatology Research 2022; 52(11) doi: 10.1111/hepr.13823
113
Corey Saraceni, John Birk. A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00095
114
Transmission routes of hepatitis C virus in Rahim Yar Khan: hospital based study. International Journal of Biosciences (IJB) 2019;  doi: 10.12692/ijb/15.5.418-424
115
V. V. Kupriyanov, L. I. Nikolaeva, A. A. Zykova, M. D. Stuchinskaya, E. A. Blokhina, N. V. Ravin. Recombinant Proteins Containing Hepatitis C Virus Protein Epitopes Fused with One, Two, or Three Copies of a Lipopeptide Form Nanoparticles of Different Sizes and Differing in Immunological Properties. Russian Journal of Bioorganic Chemistry 2026; 52(4) doi: 10.1134/S1068162025604975
116
Noila Talipova, Bakhtiyar Iriskulov, Sevara Azimova, Shakhnoza Latipova, D.V. Rudoy, A.V. Olshevskaya, E.N. Ponomareva, M.Yu. Odabashyan. Genetic characteristics of the course of chronic hepatitis. E3S Web of Conferences 2023; 381 doi: 10.1051/e3sconf/202338101098
117
Ahmed A. Ali, Ashraf A. Tabll. Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development. Virology 2025; 602 doi: 10.1016/j.virol.2024.110307
118
Ran Chen, Moubin Lin, Daming Gao. Major genomic mutations driving hepatocellular carcinoma. Genome Instability & Disease 2023; 4(4) doi: 10.1007/s42764-023-00103-7
119
Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography. Journal of Clinical Medicine 2021; 10(12) doi: 10.3390/jcm10122575
120
Uma Maheswari Chandramohan, Margavelu Gopinath. Unveiling the Therapeutic Potential of Tabernaemontana Divaricata Against HCV and Cancer: A Combined Computational and Experimental Approach. ChemistrySelect 2025; 10(41) doi: 10.1002/slct.202504029
121
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
122
Shereen A Saleh, Mohamed M Salama, Marwan M Alhusseini, Ghada A Mohamed. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. World Journal of Gastroenterology 2020; 26(21): 2864-2876 doi: 10.3748/wjg.v26.i21.2864
123
Rina Puspitasari, Tutik Sri Wahyuni, Achmad Fuad Hafid, Adita Ayu Permanasari, Lidya Tumewu, Aty Widyawaruyanti. Anti-Hepatitis C Virus Activity of Various Indonesian Plants from Balikpapan Botanical Garden, East Borneo. JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA 2022; 9(1) doi: 10.20473/jfiki.v9i12022.48-54
124
Essam Al Ageeli, Jawaher A. Abdulhakim, Mohammad H. Hussein, Maryam M. Alnoman, Samia S. Alkhalil, Peter P. Issa, Nader A. Nemr, Ahmed Abdelmaksoud, Dhaifallah A. Alenizi, Manal S. Fawzy, Eman A. Toraih. The HCV-Melanoma Paradox: First Multi-Cohort and Molecular Net-Work Analysis Reveals Lower Incidence but Worse Outcomes—Integrating Clinical, Real-World, and In Silico Data. Medicina 2024; 60(9) doi: 10.3390/medicina60091531
125
Demin Yu, Xinxin Zhang. Molecular Medical Microbiology. 2024;  doi: 10.1016/B978-0-12-818619-0.00119-2
126
Ashima Kukkar, Jasminder Kaur Sandhu. Data Science and Artificial Intelligence for Digital Healthcare. Signals and Communication Technology 2024;  doi: 10.1007/978-3-031-56818-3_6
127
Karim Nader, Amro Shetta, Sameh Saber, Wael Mamdouh. The potential of carbon-based nanomaterials in hepatitis C virus treatment: a review of carbon nanotubes, dendrimers and fullerenes. Discover Nano 2023; 18(1) doi: 10.1186/s11671-023-03895-5
128
Ahmet AKTAŞ, Engin ALTİNKAYA. DİREKT ETKİLİ ANTİVİRAL TEDAVİ ALAN KRONİK HEPATİT C HASTALARINDA ALFA FETOPROTEİN SONUÇLARININ DEĞERLENDİRİLMESİ. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 2021; 23(2) doi: 10.24938/kutfd.869839
129
Pei Zhou, Yawen Hu, Xiaoyan Wang, Luxuan Shen, Xinghao Liao, Yajuan Zhu, Jiadong Yu, Fulei Zhao, Yi Zhou, Hengshui Shen, Jiong Li. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.877939
130
Hyo Geun Choi, Jae Seung Soh, Jae Sung Lim, Song Yong Sim, Suk Woo Lee. Association between dementia and hepatitis B and C virus infection. Medicine 2021; 100(29) doi: 10.1097/MD.0000000000026476
131
KANNAN NARAYANAN, SUE ANN ZACHARIAH, SHEELA KURIAN V. ASPARTATE PLATELET RATIO INDEX AS A PREDICTOR OF SEVERITY OF FIBROSIS IN CHRONIC HEPATITS C. Asian Journal of Pharmaceutical and Clinical Research 2023;  doi: 10.22159/ajpcr.2023.v16i4.47535
132
Talari Praveen. Advances in Hepatology. 2021;  doi: 10.5772/intechopen.96734
133
G.S. Pancar, T. Kaynar. Nailfold capillaroscopic changes in patients with chronic viral hepatitis. Microvascular Research 2020; 129 doi: 10.1016/j.mvr.2019.103970
134
Antoni Sicras Mainar, Ruth Navarro Artieda, Ignacio Hernández, Ramón Morillo. Prevalencia de las potenciales interacciones medicamentosas entre los antivirales de acción directa pangenotípicos y la medicación concomitante asociada a los pacientes con infección del virus de la hepatitis C crónica en España. Gastroenterología y Hepatología 2019; 42(8) doi: 10.1016/j.gastrohep.2019.03.014
135
Thanjavur Naveen, Lankipalli Tharachand Naidu, Rayi Ramesh, Mekala Charitha Devi. Recent Developments in Applied Microbiology and Biochemistry. 2021;  doi: 10.1016/B978-0-12-821406-0.00005-9
136
Yousra A. El-Maradny, Marwa M. Abu-Serie, Mona H. Hashish, Heba S. Selim, Abdulrahman M. Saleh, Esmail M. El-Fakharany. Biochemical characterization of a novel purified lectin extracted from Pleurotus ostreatus mushroom for its antiviral activity. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-09967-z
137
Sumeet Singh, Manjusha Pal, Samita Verma, Mukesh Samant. Cytokine Response Against Major Human Viral Infections. 2025;  doi: 10.1016/B978-0-443-15283-2.00011-7
138
Mohammad Niaz Morshed Khan, Samira Dishti Irfan, Md. Alamgir Hossain, Michiko Moriyama, Sharful Islam Khan. “Sharing is my only option”: an ethnographic analysis of the underlying contexts of needle and syringe sharing among people who inject drugs using the socio-ecological framework. Frontiers in Public Health 2025; 13 doi: 10.3389/fpubh.2025.1527307
139
María Fernanda Guerra, Javier Ampuero, Manuel Romero‐Gómez. Clinical Dilemmas in Viral Liver Disease. 2020;  doi: 10.1002/9781119533481.ch10
140
Anika Jabin, Mohammad Fahim Uddin, Salauddin Al Azad, Ashfaque Rahman, Fawzia Tabassum, Pritthy Sarker, A K M Helal Morshed, Samiur Rahman, Fatima Fairuz Raisa, Musfiqur Rahman Sakib, Abeer Hasan Olive, Tabassum Islam, Ramisha Tahsin, Shahlaa Zernaz Ahmed, Partha Biswas, Mst. Umme Habiba, Mahbuba Siddiquy, Maryam Jafary. Target-specificity of different amyrin subunits in impeding HCV influx mechanism inside the human cells considering the quantum tunnel profiles and molecular strings of the CD81 receptor: a combined in silico and in vivo study. In Silico Pharmacology 2023; 11(1) doi: 10.1007/s40203-023-00144-6